Skip to content
PIL Logo

Gazyvaro 1,000 mg concentrate for solution for infusion

Last Updated on eMC 06-Dec-2017 View document  | Roche Products Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06-Dec-2017 and displayed until Current

Reasons for adding or updating:

  • Improved presentation of PIL
  • Change to section 6 - date of revision

Updated on 21-Sep-2017 and displayed until 06-Dec-2017

Reasons for adding or updating:

  • Change to information for healthcare professionals
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to section 3 - how to take/use
  • Change to section 1 - what the product is used for

Updated on 17-Jun-2016 and displayed until 21-Sep-2017

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - use in children/adolescents
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 17-Jun-2015 and displayed until 17-Jun-2016

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to information for healthcare professionals

Updated on 31-Jul-2014 and displayed until 17-Jun-2015

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Roche Products Limited

Company image
Address

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW

Fax

+44 (0)1707 338 297

Medical Information e-mail
Medical Information Fax

+44 (0)1707 384555

Telephone

+44 (0)1707 366 000

Medical Information Direct Line

+44 (0)800 328 1629

Customer Care direct line

+44 (0)800 731 5711

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

obinutuzumab

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue